Navigation Links
Verenium Receives CLARUS Award at MDB Capital's Bright Lights Conference 2011
Date:5/17/2011

SAN DIEGO, May 17, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it received the CLARUS Award presented by MDB Capital Group at the second annual Bright Lights Conference in New York City on May 10th.  The Bright Lights Conference is the only conference with an exclusive focus on publicly-traded companies possessing disruptive and market changing IP, providing institutional investors with a venue to discover the largely unrecognized value of embedded IP.

"Verenium was the top company in its industry with the highest Tech Score and number of patent grants, and we are honored to recognize their achievements in driving IP as an asset class and the impact they are making on innovation in America," commented Christopher A. Marlett, CEO of MDB Capital Group.

Verenium's technology was selected from MDB's 2011 group of "Best and Brightest" small-cap companies, a group that is advancing some of today's most innovative and market-leading intellectual property (IP) and advanced as one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform. Verenium was recognized for its innovation leadership and achieving the highest Tech Score and number of patent grants.

"We are honored to have received the CLARUS award, further affirmation of the strength of Verenium's intellectual property and core technology platform," said James Levine, President and Chief Executive Officer at Verenium.  "Verenium's proven proprietary technology enables the rapid discovery and evolution of uniquely tailored enzymes optimized for performance in challengi
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Verenium to Present at Upcoming Conferences
2. Verenium to Speak at the 2011 BIO World Congress on Industrial Biotechnology and Bioprocessing
3. Verenium to Present at MDB Capital Groups Bright Lights Conference
4. Verenium Announces Debt Repurchase
5. Worlds Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Vereniums Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval
6. Verenium Corporation to Announce Fourth Quarter and Year-End 2010 Financial Results
7. Verenium to Present at Jefferies 11th Global Clean Technology Conference
8. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
9. Verenium to Present at Piper Jaffray Sixth Annual Clean Technology & Renewables Conference
10. Verenium Reports Financial Results for the Third Quarter 2010
11. Verenium to Present at Jefferies 10th Global Clean Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 The Academy of Model Aeronautics ... school graduates from across the nation. , The Academy ... qualified AMA Youth Members with scholarships to pursue technical ... Program has awarded nearly $900,000 to college-bound aero-modelers. The ... organizations and individuals, AMA member donations, a portion of ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Market ... (Chem-Report ) signed a partnership agreement for quality ... authorised to distribute and sell research reports worked ... at Partners Department, commented upon the agreement: “Chem-Report ... on key petroleum and chemical markets on global ...
(Date:5/29/2015)... 2015 When a leading manufacturer ... request to design an industrial oven ... medications being produced using a 3D-printing process, Gruenberg ... robotic gantry, heat-saving windows, and internal actuators and ... 3D-printed pills to exact specifications. , To ensure ...
(Date:5/29/2015)... Texas , May 29, 2015  Caris ... focused on fulfilling the promise of precision medicine, ... studies that demonstrate the clinical utility of Caris ... tumor profiling service, in helping to identify targeted ... tumors. In each of the studies, results of ...
Breaking Biology Technology:Academy of Model Aeronautics Awards $46,500 in Scholarships to College-Bound Model Aviation Pilots 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6
... 7 King Pharmaceuticals, Inc. (NYSE: KG ) and ... on July 2, 2009, King met with the US Food and ... New Drug Application (NDA) for REMOXY(R). The outcome of this ... REMOXY(R) NDA and to address all FDA comments in the Complete ...
... Blood America, Inc. (OTC Bulletin Board: CBAI), one of the ... http://www.cordblood-america.com ) focused on bringing the life ... said today that it has entered into a definitive agreement ... has secured a $7.5 million investment capital commitment, which may ...
... PLAINS, N.Y., July 6 The Leukemia & Lymphoma ... have partnered in an initiative to develop stable and ... made widely available to researchers to test potential new ... as low-grade B-cell non-Hodgkin lymphoma, characterized by B-lymphocytes in ...
Cached Biology Technology:King and Pain Therapeutics Announce REMOXY(R) NDA Update 2King and Pain Therapeutics Announce REMOXY(R) NDA Update 3Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock 2Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock 3The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 2The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 3
(Date:5/21/2015)... The Sync Project™ , a global ... today announced a collaborative partnership with Berklee,s Institute ... on collaboration on original research, joint course development and ... collaboration, The Sync Project and BerkleeICE are exploring the ... the 2015-2016 academic year.  The course ...
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly advancing, ... and in the cloud. Passwords and their management are ... OTP and standards-based specifications such as those developed by ... use of passwords presents for BYOD, COPE, IoT, and ... biometric identity protocol. In response to ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... 2007 MIT Holding, Inc. (OTCBB: MITD), in collaboration ... prototype designs of the patent pending PROVECTOR. This small ... pathogens and parasites found in mosquitoes that carry deadly ... virus. The PROVECTOR will initially be made available in ...
... are on the trail of Iapetus, mysterious dark side, ... process that is transporting vaporised water ice from the ... moon. This ,thermal segregation, model may explain many ... which have been revealed in exquisite detail in images ...
... megadroughts more extreme and widespread than any previously known for ... tropical Africa was an arid scrubland during the early Late ... and the evolution of fishes in Africa,s Great Lakes. ... world, acts as a rain gauge," said lead scientist Andrew ...
Cached Biology News:MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR 2Cassini on the trail of a runaway mystery 2Cassini on the trail of a runaway mystery 3Newfound ancient African megadroughts may have driven the evolution of humans and fishes 2Newfound ancient African megadroughts may have driven the evolution of humans and fishes 3Newfound ancient African megadroughts may have driven the evolution of humans and fishes 4
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
PI/RNase Staining Buffer Solution , 100 ml Consult technical datasheet for details....
Oct 2 Immunogen: Full length human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
Biology Products: